Document is current
Any future updates will be listed below
-
Authors
Nordkild, SB
Ahlborn, LB
Yde, CW
Kugler, JM
Klubien, J.
Akdag, D.
Willemoe, GL
Nielsen, SD
Pommergaard, Hans-Christian
-
Funding
Funding for this research was provided by:
National Hospital
- License Information
-
More Information
Article History
Received: 27 September 2023
Accepted: 28 February 2024
First Online: 27 March 2024
Declarations
:
: The study was approved by the regional ethics committee (journal-nr.: H-18015944).
: Informed consent has been obtained by all participants.
: HC Pommergaard: Research grants from Danish Cancer Society, Svend Andersen Fund, Harboe Fund, Dagmar Marshalls Fund, and The Danish National Center for Circulating Tumor DNA Guided Cancer Treatment.SD Nielsen: Research grant from Novo Nordic Foundation and participation in advisory board for Gilead, Merck, and GSK.SB Nordkild, LB Ahlborn, CW Yde, JM Kugler, J Klubien, GD Akdag, and GL Willemoe: no competing interest.
